InMed Pharmaceuticals Inc.

Nasdaq:INM

Pharmaceutical Preparations·VANCOUVER, A1

The Irish Network of Medical Educators (INMED) is an interprofessional association for healthcare education professionals in Ireland. INMED was founded in 2008 by National University of Ireland, Galway, Queen's University Belfast, Royal College of Physicians of Ireland, Royal College of Surgeons in Ireland, University College Cork, University College Dublin, and Trinity College Dublin.

CEO

Adams Eric A

CFO

Jagpal Netta

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/11/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-K/A	FY 2025	6/30/25	10/24/25	→
10-K	FY 2025	6/30/25	9/23/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-Q	Q4 2024	12/31/24	2/12/25	→
↓

News (8-K)

80 shown

Filed	Type	Description
3/6/26	Reg FD	Costs Associated with Exit or Disposal Activities	→
2/12/26	Reg FD	Regulation FD Disclosure	→
12/18/25	Reg FD	Submission of Matters to a Vote of Security Holders	→
12/15/25	Other	Other Events	→
11/19/25	Reg FD	Regulation FD Disclosure	→
10/16/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/8/25	S-8	REGISTRATION STATEMENT	→
8/5/25	424B3	424B3	→
8/1/25	S-1/A	PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1	→
7/9/25	S-1	REGISTRATION STATEMENT	→
1/2/25	424B3	424B3	→
12/30/24	S-1/A	PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1	→
↓

Filing History(459 filings)

TypeDateAccessionPeriodSize

8-K

Mar 6, 2026

0001213900-26-024752CURRENT REPORT

Mar 4, 2026

315.6 KB

8-K

Feb 12, 2026

0001062993-26-000819FORM 8-K

Feb 11, 2026

387.1 KB

10-Q

Feb 11, 2026

0001213900-26-014996QUARTERLY REPORT

Dec 31, 2025

4.6 MB

SCHEDULE 13G

Jan 20, 2026

0001535610-26-000009

—

9.0 KB

Dec 19, 2025

0001213900-25-123639

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123637

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123636

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123635

Dec 19, 2025

5.4 KB

Dec 19, 2025

0001213900-25-123633

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123630

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123628

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123625

Dec 19, 2025

5.3 KB

Dec 19, 2025

0001213900-25-123620

Dec 19, 2025

5.4 KB

8-K

Dec 18, 2025

0001062993-25-017390FORM 8-K

Dec 17, 2025

277.1 KB

Dec 17, 2025

0001213900-25-122649

Dec 15, 2025

5.3 KB

Dec 17, 2025

0001213900-25-122647

Dec 15, 2025

5.3 KB

Dec 17, 2025

0001213900-25-122645

Dec 15, 2025

5.4 KB

Dec 17, 2025

0001213900-25-122641

Dec 15, 2025

5.3 KB

8-K

Dec 15, 2025

0001213900-25-121497CURRENT REPORT

Dec 12, 2025

225.1 KB

S-8

Dec 8, 2025

0001213900-25-119262REGISTRATION STATEMENT

—

242.8 KB

8-K

Nov 19, 2025

0001213900-25-112644CURRENT REPORT

Nov 18, 2025

228.9 KB

10-Q

Nov 6, 2025

0001213900-25-107152QUARTERLY REPORT

Sep 30, 2025

4.3 MB

DEFA14A

Nov 3, 2025

0001213900-25-104915DEFINITIVE ADDITIONAL MATERIALS

—

44.5 KB

DEF 14A

Nov 3, 2025

0001213900-25-104914DEFINITIVE PROXY STATEMENT

Dec 17, 2025

4.4 MB

PRE 14A

Oct 24, 2025

0001213900-25-102234PRELIMINARY PROXY STATEMENT

Oct 24, 2025

611.6 KB

25 filings shown

InMed Pharmaceuticals Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(459 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/3/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
11/3/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
10/24/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
5/29/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
5/16/25	DEF 14A	DEF 14A	→
4/29/25	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	4	4	→
12/19/25	4	4	→
↓

Filed	Form	Description
1/20/26	SCHEDULE 13G	SCHEDULE 13G	→
8/1/25	EFFECT	EFFECT	→
4/2/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/3/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/31/24	EFFECT	EFFECT	→
12/18/24	SCHEDULE 13G	SCHEDULE 13G	→
↓